NK-3

CAT # Igama lemveliso Inkcazo
CPD100768 I-Fezolinetant I-Fezolinetant, ekwabizwa ngokuba yi-ESN-364, yi-Neurokinin-3 (NK-3) ye-receptor antagonist eye yalungiselelwa ukusetyenziswa kwimpilo yabasetyhini, kwaye iphuhliselwa ukuphazamiseka okunxulumene ne-sex-hormone efana ne-endometriosis, i-polycystic ovarian syndrome kunye ne-uterine fibroids. . I-Fexolinetant ivumela ukuguqulwa kwe-hypothalamic-pituitary gonadal axis kunye nesenzo esikhethiweyo kwiihomoni ezifanelekileyo kwisifo. I-arhente kulindeleke ukuba ibe nokunyamezela okukhulu kuneemveliso ezikhuphisanayo ezijolise kwi-GnRH (i-Gonadotropin-releasing hormone).

Qhagamshelana nathi

Ukubuza

Iindaba zamva

  • Iindlela eziPhezulu ze-7 kuPhando lwezoPhando kwi-2018

    IiNdlela ezi-7 eziphambili kuPhando lwaMayeza...

    Ukuba phantsi koxinzelelo oluhlala lukhula lokukhuphisana kwimeko yezoqoqosho kunye nethekhinoloji ecela umngeni, iinkampani zamayeza kunye nebhayoloji kufuneka ziqhubeke zenza izinto ezintsha kwiinkqubo zazo zeR&D ukuze zihlale phambili ...

  • I-ARS-1620: I-inhibitor entsha ethembisayo ye-KRAS-mutant cancers

    I-ARS-1620: Isithinteli esitsha esithembisayo se-K...

    Ngokophononongo olupapashwe kwiSeli, abaphandi baye baphuhlisa inhibitor ethile ye-KRASG12C ebizwa ngokuba yi-ARS-1602 ebangele ukuhlehla kwethumba kwiimpuku. "Olu phononongo lubonelela ngobungqina bokuba i-KRAS eguqukayo inokuba...

  • I-AstraZeneca ifumana unyuso lolawulo lwamachiza e-oncology

    I-AstraZeneca ifumana unyuso lolawulo lwe...

    I-AstraZeneca ifumene ukongezwa okuphindwe kabini kwipotfoliyo yayo ye-oncology ngoLwesibini, emva kokuba abalawuli base-US naseYurophu bamkele ukungeniswa kolawulo lwamachiza ayo, inyathelo lokuqala lokuphumelela ukuvunywa kwala mayeza. ...

Incoko ka-WhatsApp kwi-Intanethi!